Cargando…

Deep sedation protocol during atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter

BACKGROUND: Pulsed field ablation (PFA) is a novel, largely nonthermal ablative modality that, by virtue of its putative preferential action on myocardial tissue through the process of irreversible electroporation (IRE), may replace conventional thermal ablation for atrial fibrillation (AF). The rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Grimaldi, Massimo, Quadrini, Federico, Caporusso, Nicola, Troisi, Federica, Vitulano, Nicola, Delmonte, Vito, Di Monaco, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434733/
https://www.ncbi.nlm.nih.gov/pubmed/37470452
http://dx.doi.org/10.1093/europace/euad222
_version_ 1785091973592383488
author Grimaldi, Massimo
Quadrini, Federico
Caporusso, Nicola
Troisi, Federica
Vitulano, Nicola
Delmonte, Vito
Di Monaco, Antonio
author_facet Grimaldi, Massimo
Quadrini, Federico
Caporusso, Nicola
Troisi, Federica
Vitulano, Nicola
Delmonte, Vito
Di Monaco, Antonio
author_sort Grimaldi, Massimo
collection PubMed
description BACKGROUND: Pulsed field ablation (PFA) is a novel, largely nonthermal ablative modality that, by virtue of its putative preferential action on myocardial tissue through the process of irreversible electroporation (IRE), may replace conventional thermal ablation for atrial fibrillation (AF). The recent inspIRE study confirmed safety and effectiveness of a fully integrated biphasic PFA system with a variable loop circular catheter for the treatment of paroxysmal AF. The majority of PFA procedures were performed using general anesthesia. However, due to the risks of general anesthesia we report the data regarding our sedation protocol used during inspIRE study. METHODS: A total of 29 patients (mean age 55±9 years; 72% male) were enrolled as part of this analysis within the inspIRE trial. The sedation protocol is reported in the manuscript. The Richmond Agitation-Sedation Scale (RASS), the Visual Analogue Scale (VAS) and the Patient State Index were collected during sedation. Each patient was monitored using the Masimo Sedline. At the end of ablation, the Likert Scale Questionnaire (LSQ) was used to assess the patients' satisfaction with intraoperative analgesia-sedation. RESULTS: No procedural complications were documented. Sufficient oxygen saturation was maintained in all patients during procedure. Non-invasive ventilation or tracheal intubation were not required for any patient. The RAAS score between -1 to -5 was obtained in 27 patients (93%) while the value 0 was obtained in 2 patients (7%). The VAS score between 0 to 2 was obtained in 24 patients (83%); the VAS score 3 in 3 patients (10%) and the VAS score 4 in 2 patients (7%). The PSI score <50 was achieved in 16 patients (55%) while the PSI between 50 and 70 was achieved in 9 patients (31%). Positive answers to LSQ were obtained in most patients. CONCLUSION: During PFA ablation procedures with the variable-loop circular catheter and its accompanying biphasic pulse, our deep sedation protocol is a valid alternative to general anesthesia.
format Online
Article
Text
id pubmed-10434733
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-104347332023-08-18 Deep sedation protocol during atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter Grimaldi, Massimo Quadrini, Federico Caporusso, Nicola Troisi, Federica Vitulano, Nicola Delmonte, Vito Di Monaco, Antonio Europace Research Letter BACKGROUND: Pulsed field ablation (PFA) is a novel, largely nonthermal ablative modality that, by virtue of its putative preferential action on myocardial tissue through the process of irreversible electroporation (IRE), may replace conventional thermal ablation for atrial fibrillation (AF). The recent inspIRE study confirmed safety and effectiveness of a fully integrated biphasic PFA system with a variable loop circular catheter for the treatment of paroxysmal AF. The majority of PFA procedures were performed using general anesthesia. However, due to the risks of general anesthesia we report the data regarding our sedation protocol used during inspIRE study. METHODS: A total of 29 patients (mean age 55±9 years; 72% male) were enrolled as part of this analysis within the inspIRE trial. The sedation protocol is reported in the manuscript. The Richmond Agitation-Sedation Scale (RASS), the Visual Analogue Scale (VAS) and the Patient State Index were collected during sedation. Each patient was monitored using the Masimo Sedline. At the end of ablation, the Likert Scale Questionnaire (LSQ) was used to assess the patients' satisfaction with intraoperative analgesia-sedation. RESULTS: No procedural complications were documented. Sufficient oxygen saturation was maintained in all patients during procedure. Non-invasive ventilation or tracheal intubation were not required for any patient. The RAAS score between -1 to -5 was obtained in 27 patients (93%) while the value 0 was obtained in 2 patients (7%). The VAS score between 0 to 2 was obtained in 24 patients (83%); the VAS score 3 in 3 patients (10%) and the VAS score 4 in 2 patients (7%). The PSI score <50 was achieved in 16 patients (55%) while the PSI between 50 and 70 was achieved in 9 patients (31%). Positive answers to LSQ were obtained in most patients. CONCLUSION: During PFA ablation procedures with the variable-loop circular catheter and its accompanying biphasic pulse, our deep sedation protocol is a valid alternative to general anesthesia. Oxford University Press 2023-07-20 /pmc/articles/PMC10434733/ /pubmed/37470452 http://dx.doi.org/10.1093/europace/euad222 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Research Letter
Grimaldi, Massimo
Quadrini, Federico
Caporusso, Nicola
Troisi, Federica
Vitulano, Nicola
Delmonte, Vito
Di Monaco, Antonio
Deep sedation protocol during atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter
title Deep sedation protocol during atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter
title_full Deep sedation protocol during atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter
title_fullStr Deep sedation protocol during atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter
title_full_unstemmed Deep sedation protocol during atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter
title_short Deep sedation protocol during atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter
title_sort deep sedation protocol during atrial fibrillation ablation using a novel variable-loop biphasic pulsed field ablation catheter
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434733/
https://www.ncbi.nlm.nih.gov/pubmed/37470452
http://dx.doi.org/10.1093/europace/euad222
work_keys_str_mv AT grimaldimassimo deepsedationprotocolduringatrialfibrillationablationusinganovelvariableloopbiphasicpulsedfieldablationcatheter
AT quadrinifederico deepsedationprotocolduringatrialfibrillationablationusinganovelvariableloopbiphasicpulsedfieldablationcatheter
AT caporussonicola deepsedationprotocolduringatrialfibrillationablationusinganovelvariableloopbiphasicpulsedfieldablationcatheter
AT troisifederica deepsedationprotocolduringatrialfibrillationablationusinganovelvariableloopbiphasicpulsedfieldablationcatheter
AT vitulanonicola deepsedationprotocolduringatrialfibrillationablationusinganovelvariableloopbiphasicpulsedfieldablationcatheter
AT delmontevito deepsedationprotocolduringatrialfibrillationablationusinganovelvariableloopbiphasicpulsedfieldablationcatheter
AT dimonacoantonio deepsedationprotocolduringatrialfibrillationablationusinganovelvariableloopbiphasicpulsedfieldablationcatheter